Usa Financial Portformulas Corp Abb Vie Inc. Transaction History

Usa Financial Portformulas Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $700,441 - $803,360	-5,219 Reduced 99.62%	20 $3,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $172,025 - $218,700	-1,250 Reduced 19.26%	5,239 $802,000
Q1 2022 Aug 16, 2022	BUY	$131.98 - $163.75 $852,986 - $1.06 Million	6,463 Added 24857.69%	6,489 $1.05 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $60,160 - $76,120	-560 Reduced 95.56%	26 $4,000
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $10,852 - $12,319	102 Added 21.07%	586 $63,000
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $48,291 - $53,799	459 Added 1836.0%	484 $55,000
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $77,134 - $84,915	-754 Reduced 96.79%	25 $3,000
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $62,701 - $84,653	779 New	779 $83,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $201,242 - $248,185	-2,585 Closed	0 $0
Q3 2018 Oct 31, 2018	SELL	$88.91 - $98.84 $2.8 Million - $3.11 Million	-31,475 Reduced 92.41%	2,585 $240,000
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $23,163 - $27,407	-258 Reduced 0.75%	34,060 $3.22 Million
Q1 2018 Apr 03, 2018	SELL	$92.01 - $123.21 $454,989 - $609,273	-4,945 Reduced 12.59%	34,318 $3.25 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $3.52 Million - $3.86 Million	39,263 New	39,263 $3.8 Million
Q3 2017 Oct 11, 2017	SELL	$69.85 - $89.22 $411,206 - $525,238	-5,887 Closed	0 $0
Q2 2017 Aug 23, 2017	BUY	N/A	5,887	5,887 $427,000

3,958

1.26B

16.9M

13M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.